SMSPHARMASMS Pharmaceuticals Limited
Pharma · Drug Manufacturers - General · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
Why buy
- • Debt/Equity: 0.46
- • Promoter holding: 76.5%
- • Valuation vs sector: P/E 41.9 vs sector 40.5
- • MACD: bullish
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Breakout with Volume signal (setup quality 88%)
- • 52-Week High Breakout signal (setup quality 87%)
Bull case
- • Debt/Equity: 0.46
- • Promoter holding: 76.5%
- • Valuation vs sector: P/E 41.9 vs sector 40.5
- • MACD: bullish
Bear case
- • Revenue growth: 5.6% YoY
- • Profit growth: -3.5% YoY
- • Volatility: 49% annualized
Key risks
- • Revenue growth: 5.6% YoY
- • Profit growth: -3.5% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹18.83). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.